• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods. Rapid quantification of single-nucleotide mutations in mixed Influenza A viral populations using Allele Specific Mixture Analysis.

Giuseppe

Emeritus
J Virol Methods. 2009 Sep 14. [Epub ahead of print]

Rapid quantification of single-nucleotide mutations in mixed Influenza A viral populations using Allele Specific Mixture Analysis.

Liu CM, Driebe EM, Schupp J, Kelley E, Nguyen JT, McSharry JJ, Weng Q, Engelthaler DM, Keim PS. - Division of Pathogen Genomics, Translational Genomics Research Institute (TGen). Flagstaff, AZ, USA.; The Center for Microbial Genetics and Genomics (MGGen), Northern Arizona University, Flagstaff, AZ 86001.

Monitoring antiviral resistance in influenza is critical to public health epidemiology and pandemic preparedness activities. Effective monitoring requires methods to detect low-level resistance and to monitor the change in resistance as a function of time and drug treatment. Resistance-conferring single nucleotide mutations in influenza virus are ideal targets for such methods. In the present study, fives sets of paired TaqMan(R) allele-specific PCR (ASPCR) assays were developed and validated for quantitative single-nucleotide polymorphism (SNP) analysis. This novel method using DeltaCt is termed Allele Specific Mixture Analysis (ASMA) or FluASMA. The FluASMA assays target L26F, V27A, A30T, and S31N mutations in the A/Albany/1/1998 (H3N2) M2 gene and H275Y mutation in the A/New Caledonia/20/99 (H1N1) NA gene and have a limit of quantification of 0.25%-0.50% mutant. The error for %mutant estimation was less than 10% in all FluASMA assays, with intra-run DeltaCt coefficient of variance (CoV) at less than or =2% and inter-run DeltaCt CoV at less than or =5%. Results from the current study demonstrate that FluASMA is a highly sensitive and quantitative SNP analysis method, even for minor mutant components (<1%).

PMID: 19761797 [PubMed - as supplied by publisher]

-
------
 
Back
Top